| DB ID | MyCo_4082 |
| Title | The Prevalence of Bacterial and Fungal Coinfections among Critically Ill COVID-19 Patients in the ICU in Jordan |
| Year | 2022 |
| PMID | 36353524 |
| Fungal Diseases involved | Fungal infection |
| Associated Medical Condition | COVID-19 |
| Genus | Candida |
| Species | albicans |
| Organism | Candida albicans |
| Ethical Statement | Ethical approval was obtained from the Ethics Com- mittee for Scientifc Research (ECSR) at Zarqa University based on the requirement for the protection of human subjectsandtheethicalprinciplesrelatedtoresearchstudie (no.2/8/2021). |
| Site of Infection | None |
| Opportunistic invasive | None |
| Sample type | Body fluid |
| Sample source | Blood |
| Host Group | Human |
| Host Common name | Human |
| Host Scientific name | Homo sapiens |
| Biomarker Name | Ferritin |
| Biomarker Full Name | Ferritin |
| Biomarker Type | Diagnostic |
| Biomolecule | Protein |
| Geographical Location | Jordan |
| Cohort | Eighty critically ill patients were admitted to the ICU be- tween January 2020 and June 2021 in a private hospital in Amman, Jordan.AllofthemwereassessedforCOVID-19 infection by real-time reverse transcription-polymerase chain reaction (RT‒PCR). Only 46 patients fulflled the criterion and were included in the study. |
| Cohort No. | 46 |
| Age Group | 15-89 |
| P Value | 0.692 |
| Sensitivity | None |
| Specificity | None |
| Positive Predictive Value | None |
| MIC | None |
| Fold Change | None |
| Pathway | None |
| Disease Introduction Mechanism | None |
| Technique | Immunological assay |
| Analysis Method | Immunological assay |
| ELISA kits | None |
| Assay Data | None |
| Validation Techniques used | Immunological assay |
| Up Regulation Down Regulation | Increase |
| Sequence Data | None |
| External Link | None |
